
Results
2
2 companies
Starpharma Holdings
Market Cap: AU$282.2m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.68
7D
10.7%
1Y
658.4%
Clinuvel Pharmaceuticals
Market Cap: AU$450.8m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$8.94
7D
0%
1Y
-18.6%